[HTML][HTML] Forming megakaryocytes from murine induced pluripotent stem cells by the inducible overexpression of supporting factors
K Cullmann, M Jahn, M Spindler, F Schenk… - Research and Practice …, 2021 - Elsevier
Background Platelets are small anucleate cells that circulate in the blood in a resting state
but can be activated by external cues. In case of need, platelets from blood donors can be …
but can be activated by external cues. In case of need, platelets from blood donors can be …
Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents
Megakaryocytes (MKs) are rare hematopoietic cells in the adult bone marrow and produce
platelets that are critical to vascular hemostasis and wound healing. Ex vivo generation of …
platelets that are critical to vascular hemostasis and wound healing. Ex vivo generation of …
[HTML][HTML] Generating Large Numbers of Human Megakaryocytes from Pluripotent Stem Cells
J Gill, L Lin, MA Walasek, SJ Szilvassy, W Chang… - Blood, 2021 - Elsevier
The process of hemostasis and blood coagulation relies heavily on a sufficient supply of
platelets (PLTs, also known as thrombocytes) within a person's bloodstream. Platelet …
platelets (PLTs, also known as thrombocytes) within a person's bloodstream. Platelet …
[HTML][HTML] Platelet production system using an immortalized megakaryocyte cell line derived from human pluripotent stem cells
S Nakamura, N Takayama, H Nakauchi, K Eto - Blood, 2011 - Elsevier
Abstract MRG-1 Human induced pluripotent stem cells (hiPSCs) are a promising source of
blood cells, including platelets, for transfusion. However, there remains a need for: 1) a …
blood cells, including platelets, for transfusion. However, there remains a need for: 1) a …
[HTML][HTML] In vitro production of megakaryocytes and platelets from human induced pluripotent cells by GMP compatible methods
Human pluripotent stem cells and in particular induced pluripotent stem cells (iPSC) derived
from adult tissue have recently opened novel and promising avenues for cell therapy. In vitro …
from adult tissue have recently opened novel and promising avenues for cell therapy. In vitro …
[HTML][HTML] Improving human induced pluripotent stem cell-derived megakaryocyte differentiation and platelet production
L Krisch, G Brachtl, S Hochmann, AC Andrade… - International Journal of …, 2021 - mdpi.com
Several protocols exist for generating megakaryocytes (MKs) and platelets from human
induced pluripotent stem cells (hiPSCs) with limited efficiency. We observed previously that …
induced pluripotent stem cells (hiPSCs) with limited efficiency. We observed previously that …
The opportunities and challenges regarding induced platelets from human pluripotent stem cells
MX Xu, LP Liu, YM Li, YW Zheng - Stem Cells International, 2021 - Wiley Online Library
As a standard clinical treatment, platelet transfusion has been employed to prevent
hemorrhage in patients with thrombocytopenia or platelet dysfunctions. Platelets also show …
hemorrhage in patients with thrombocytopenia or platelet dysfunctions. Platelets also show …
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
C Ghevaert - 2022 - repository.cam.ac.uk
Platelet deficiency, known as thrombocytopenia, can cause haemorrhage and is treated with
platelet transfusions. We developed a system for the production of platelet precursor cells …
platelet transfusions. We developed a system for the production of platelet precursor cells …
In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells
N Takayama, K Eto - Platelets and Megakaryocytes: Volume 3, Additional …, 2012 - Springer
Human embryonic stem cells (hESCs) represent a potential source of blood cells for
transfusion therapies and a promising tool for studying the ontogeny of hematopoiesis …
transfusion therapies and a promising tool for studying the ontogeny of hematopoiesis …
Forward programming of human pluripotent stem cells to a megakaryocyte-erythrocyte bi-potent progenitor population: an in vitro system for the production of platelets …
AL Dalby - 2018 - repository.cam.ac.uk
There exists a need to produce platelets in vitro for use in transfusion medicine, due to
increased platelet demands and short shelf life. Our lab uses human induced pluripotent …
increased platelet demands and short shelf life. Our lab uses human induced pluripotent …